Description: We are a preclinical biopharmaceutical company harnessing innovative metabolomic technology to develop life-saving therapies for patients.
We are a preclinical biopharmaceutical company harnessing innovative metabolomic technology to discover and develop life-saving therapies for patients. Metaba was originally founded to develop a promising adjunctive therapeutic for treatment of Tuberculosis (TB). Through collaborations and successful pilot projects with leading global pharmaceutical companies and research institutions, we have expanded our R&D efforts to additional indications, including Covid-19, Nontuberculosis Mycobacteria (NTM), Atheros
Our Mission Our mission is to become a leader in biopharmaceutical innovation by transforming our understanding of biological systems and developing innovative therapies using our cutting-edge metabolomic technology. We leverage the versatility of our platform to expand our impact to include other serious human diseases and target additional market opportunities.
Conquering Disease through Innovative Metabolomic Technology